Blockage of JNK pathway enhances arsenic trioxide-induced apoptosis in human keratinocytes
Huei-Sheng Huang1, Zi-Miao Liu, Duang-Yang Hong
1Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. huanghs@mail.ncku.edu.tw
Abstract:
Arsenic is well known as a carcinogen predisposing humans to some severe diseases and also as an effective medicine for treating acute promyelocytic leukemia, syphilis, and psoriasis. Multiple active mechanisms, including cell cycle arrest and apoptosis, have been proposed in therapy; however, the opposing effects of arsenic remain controversial. Our previous study found that arsenic trioxide (ATO)-induced activation of p21(WAF1/CIP1) (p21) led to A431 cell death through the antagonistic effects of the signaling of ERK1/2 and JNK1. In the current study, the inhibitory effects of JNK1 on ATO-induced p21 expression were explored. Over-expression of JNK1 in A431 cells could inhibit p21 expression, which was associated with HDAC1 and TGIF. Using the GST pull-down assay and fluorescence resonance energy transfer analysis, N-terminal domain (amino acids 1-108) of TGIF, critical to its binding with c-Jun, was found. Using reporter assays, requirement of the C-terminal domain (amino acids 138-272) of TGIF to suppress ATO-induced p21 expression was observed. Thus, the domains of TGIF that carried out its inhibitory effects on p21 were identified. Finally, treatment with JNK inhibitor SP600125 could enhance ATO-induced apoptosis of HaCaT keratinocytes by using flow cytometry.
Insights
Arsenic trioxide (ATO) impacts cell death pathways. JNK1 inhibits ATO-induced p21 expression, a mechanism involving TGIF domains, and JNK inhibition enhances ATO-induced apoptosis in keratinocytes.
Area of Science:
- Cell Biology
- Molecular Biology
- Toxicology
Background:
- Arsenic compounds exhibit dual roles as carcinogens and therapeutic agents.
- Arsenic trioxide (ATO) induces cell death via mechanisms like apoptosis and cell cycle arrest.
- Previous research linked ATO-induced p21 activation to A431 cell death, involving ERK1/2 and JNK1 signaling.
Purpose of the Study:
- To investigate the inhibitory role of JNK1 in ATO-induced p21 expression.
- To identify the specific domains of TGIF responsible for its interaction with JNK1 and its effect on p21 expression.
- To evaluate the impact of JNK inhibition on ATO-induced apoptosis in keratinocytes.
Main Methods:
- Over-expression of JNK1 in A431 cells.
- GST pull-down assay and fluorescence resonance energy transfer (FRET) analysis.
- Reporter assays to determine TGIF domain function.
- Flow cytometry to assess apoptosis in HaCaT cells after treatment with JNK inhibitor SP600125 and ATO.
Main Results:
- JNK1 overexpression inhibited p21 expression in A431 cells, associated with HDAC1 and TGIF.
- The N-terminal domain (1-108) of TGIF was critical for binding with c-Jun.
- The C-terminal domain (138-272) of TGIF was required to suppress ATO-induced p21 expression.
- JNK inhibitor SP600125 enhanced ATO-induced apoptosis in HaCaT keratinocytes.
Conclusions:
- JNK1 plays an inhibitory role in ATO-induced p21 expression through interactions involving TGIF and HDAC1.
- Specific domains of TGIF mediate its inhibitory effects on p21 expression.
- Inhibiting JNK1 potentiates ATO-induced apoptosis in keratinocytes, suggesting a therapeutic avenue.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

